What is Balance Labs Inc's earnings per share (EPS)?

Balance Labs Inc (BLNC) reported diluted earnings per share of $-1.23 for fiscal year 2025. This represents a -6050.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Balance Labs Inc Financials

BLNC

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Balance Labs Inc (BLNC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BLNC FY2025 2026-05-15

FY2025 was driven more by externally funded balance-sheet repair than by revenue, with liabilities still dominating the capital structure.

Between FY2024 and FY2025, cash rose from $13K to $359K. That happened even with operating cash flow at -$257K, because financing supplied $603K and liabilities moved lower year over year. The non-obvious point is that the visible improvement came from balance-sheet repair and outside funding, not from the business starting to self-fund.

With just $6K of revenue against $206K of interest expense, the current operating footprint is too small to carry the existing obligation stack on its own. Current liabilities of $3.77M alongside a current ratio of 0.1x show that the liquidity squeeze remained severe even after the year-end cash rebuild.

For the last three years, interest expense stayed near $206K-$231K while the reported asset base shrank to as little as $96K, which makes this look more like a company carrying legacy financing costs than one supported by active operations. The improvement in FY2025 negative equity to -$3.38M from -$5.07M matters, but it does not yet change that operating-versus-obligations mismatch.

Financial Health Signals

Financial health score pending refresh

We are recalculating Balance Labs Inc's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6K

5Y CAGR-64.1%

10Y CAGR-17.1%

Balance Labs Inc generated $6K in revenue in fiscal year 2025.

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$-1.23

YoY-6050.0%

Balance Labs Inc earned $-1.23 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 6050.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$359K

YoY+2619.7%

5Y CAGR+129.6%

10Y CAGR+34.1%

Balance Labs Inc held $359K in cash against $25K in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

47M

YoY+116.2%

5Y CAGR+16.7%

10Y CAGR+8.6%

Balance Labs Inc had 47M shares outstanding in fiscal year 2025. This represents an increase of 116.2% from the prior year.

Margins & Returns

Gross Margin

100.0%

Balance Labs Inc's gross margin was 100.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs.

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

BLNC Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$6K	N/A	N/A	$248K-60.4%	$625K-37.5%	$1.0M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$6K	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$19K+37.7%	$14K-61.6%	$36K+67.5%	$21K-29.1%	$30K-18.8%	$37K
Operating Income	N/A	-$271K-133.3%	-$116K-409.3%	-$23K-110.2%	$224K-63.4%	$613K
Interest Expense	$206K-11.0%	$231K+3.1%	$224K-3.1%	$232K-5.2%	$244K+18.7%	$206K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	-$382K+50.3%	-$768K+3.6%	-$797K-322.7%	$358K
EPS (Diluted)	$-1.23-6050.0%	$-0.020.0%	$-0.02-150.0%	$0.040.0%	$0.04+100.0%	$0.02

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$33K+444.4%	$6K	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$6K	N/A	$4K-26.1%	$6K+37.1%	$4K	N/A	$5K+43.3%	$3K
Operating Income	-$488K	N/A	-$211K-166.4%	-$79K-0.5%	-$79K	N/A	-$84K-44.6%	-$58K
Interest Expense	$12K	N/A	$61K+7.7%	$57K-0.4%	$57K	N/A	$61K+7.9%	$57K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	$178K	N/A	N/A	-$146K-2181.3%	-$6K	N/A	-$193K-91.5%	-$101K
EPS (Diluted)	$0.00	N/A	$-0.16-1500.0%	$-0.01	$0.00	N/A	$-0.01	$0.00

BLNC Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$398K+315.9%	$96K-56.7%	$221K-48.6%	$429K-57.7%	$1.0M-20.1%	$1.3M
Current Assets	$398K+315.9%	$96K-56.7%	$221K-48.6%	$429K-56.0%	$976K+3085.4%	$31K
Cash & Equivalents	$359K+2619.7%	$13K-88.3%	$113K-52.1%	$235K+3.4%	$228K+3940.4%	$6K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	$45K+100.0%	$23K	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$3.8M-27.0%	$5.2M+8.5%	$4.8M+3.8%	$4.6M+4.2%	$4.4M+14.3%	$3.9M
Current Liabilities	$3.8M-27.0%	$5.2M+8.5%	$4.8M+15.9%	$4.1M+4.4%	$3.9M+16.3%	$3.4M
Long-Term Debt	$25K	N/A	$491K+2.4%	$480K	N/A	N/A
Total Equity	-$3.4M+33.4%	-$5.1M-11.6%	-$4.5M-9.2%	-$4.2M-22.6%	-$3.4M-33.9%	-$2.5M
Retained Earnings	-$37.7M-540.0%	-$5.9M-9.9%	-$5.4M-7.7%	-$5.0M-18.3%	-$4.2M-25.8%	-$3.3M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$260K-34.7%	$398K+648.0%	$53K-31.2%	$77K-11.2%	$87K-9.0%	$96K-13.4%	$110K-35.7%	$171K
Current Assets	$260K-34.7%	$398K+648.0%	$53K-31.2%	$77K-11.2%	$87K-9.0%	$96K-13.4%	$110K-35.7%	$171K
Cash & Equivalents	$216K-39.7%	$359K+7856.0%	$5K+24.5%	$4K+19.2%	$3K-77.0%	$13K-56.6%	$30K-30.6%	$44K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$3.1M-17.1%	$3.8M-56.8%	$8.7M+64.7%	$5.3M+2.6%	$5.2M0.0%	$5.2M+2.0%	$5.1M+2.7%	$4.9M
Current Liabilities	$3.1M-17.1%	$3.8M-56.8%	$8.7M+64.7%	$5.3M+2.6%	$5.2M0.0%	$5.2M+2.0%	$5.1M+2.7%	$4.9M
Long-Term Debt	N/A	$25K-95.2%	$525K0.0%	$525K0.0%	$525K	N/A	N/A	$497K
Total Equity	-$2.9M+15.0%	-$3.4M+61.1%	-$8.7M-66.1%	-$5.2M-2.9%	-$5.1M-0.1%	-$5.1M-2.4%	-$5.0M-4.1%	-$4.8M
Retained Earnings	-$37.5M+0.5%	-$37.7M-291.0%	-$9.6M-59.6%	-$6.0M-2.5%	-$5.9M-0.1%	-$5.9M-2.0%	-$5.8M-3.5%	-$5.6M

BLNC Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$257K-63.6%	-$157K-28.3%	-$123K-1680.1%	$8K+113.6%	-$57K+73.9%	-$218K
Capital Expenditures	N/A	N/A	N/A	N/A	$10K	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	-$66K	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	-$204K-1063.9%	-$18K
Financing Cash Flow	$603K+948.3%	$58K	N/A	N/A	$483K+108.0%	$232K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$143K+12.8%	-$164K-355.4%	-$36K-2.9%	-$35K-54.1%	-$23K+49.3%	-$45K-3.0%	-$43K+37.1%	-$69K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$13K-97.6%	$518K+1307.6%	$37K+3.7%	$36K+184.0%	$13K-54.5%	$28K	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

BLNC Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	100.0%	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	-9.2%-45.2pp	35.9%-25.3pp	61.3%
Net Margin	N/A	N/A	N/A	-310.4%-182.9pp	-127.6%-163.3pp	35.8%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	-172.9%+6.2pp	-179.1%-100.5pp	-78.5%-106.7pp	28.2%
Current Ratio	0.11+0.1	0.02-0.0	0.05-0.1	0.10-0.1	0.25+0.2	0.01
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A
FCF Margin	N/A	N/A	N/A	N/A	-10.6%	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-1494.1%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	544.3%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	68.5%	N/A	N/A	-189.2%-181.9pp	-7.4%	N/A	-174.8%-116.0pp	-58.7%
Current Ratio	0.08-0.0	0.11+0.1	0.010.0	0.010.0	0.020.0	0.020.0	0.02-0.0	0.03
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$3.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.11), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Crown Equity Hol CRWE

$8.1M

$17.8M

$42.5M

$7.8M

$18K

Frequently Asked Questions

What is Balance Labs Inc's annual revenue?

Balance Labs Inc (BLNC) reported $6K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How much debt does Balance Labs Inc have?

As of fiscal year 2025, Balance Labs Inc (BLNC) had $359K in cash and equivalents against $25K in long-term debt.

What is Balance Labs Inc's gross margin?

Balance Labs Inc (BLNC) had a gross margin of 100.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Balance Labs Inc's operating cash flow?

Balance Labs Inc (BLNC) generated -$257K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Balance Labs Inc's total assets?

Balance Labs Inc (BLNC) had $398K in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Balance Labs Inc have outstanding?

Balance Labs Inc (BLNC) had 47M shares outstanding as of fiscal year 2025.

What is Balance Labs Inc's current ratio?

Balance Labs Inc (BLNC) had a current ratio of 0.11 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Balance Labs Inc's cash runway?

Based on fiscal year 2025 data, Balance Labs Inc (BLNC) had $359K in cash against an annual operating cash burn of $257K. This gives an estimated cash runway of approximately 17 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Balance Labs Inc's debt-to-equity ratio negative or not reported?

Balance Labs Inc (BLNC) has negative shareholder equity of -$3.4M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.